Medical imaging market seen reaching $133.95 billion by 2035

Market Research Future projects the global medical imaging market will grow from $83.65 billion in 2025 to $133.95 billion by 2035, driven by aging populations, chronic disease growth and AI-enabled workflow gains. The forecast points to faster adoption in outpatient settings and emerging markets, with CT, diagnostic imaging and hospitals remaining key growth areas.

Why it matters: - Medical imaging sits at the center of early diagnosis, cancer staging, cardiac care and procedure guidance. - The forecast signals sustained demand from older populations and higher chronic disease burdens. - AI and new detector technologies could make scans faster and more efficient, which matters for hospital throughput and payer economics. - The market opportunity also reflects uneven imaging access, especially in lower-income countries.

What happened: - Market Research Future projected the global medical imaging market will rise from USD 83.65 billion in 2025 to USD 133.95 billion by 2035. - The forecast implies a 4.82% CAGR for 2026 through 2035. - The report identified aging populations, AI-powered reconstruction and government-led hospital expansion as the main growth drivers. - The report also said the market is shifting toward outpatient and ambulatory imaging.

The details: - The United Nations Department of Economic and Social Affairs projects the global population aged 65 and older will reach 16% by 2050, up from nearly 10% in 2022. - The FDA has cleared hundreds of AI-enabled medical devices, and radiology algorithms account for more than 75% of those authorizations. - AI-enabled software can reduce MRI scan times by up to 50% while preserving diagnostic quality. - AI-powered reconstruction can cut scan times on high-end CT and MRI platforms by 40% to 60%. - India’s Ayushman Bharat program operationalized more than 181,000 Health and Wellness Centres by late 2025. - China’s 14th Five-Year Plan is driving major capital equipment installation activity. - The European Commission earmarked EUR 4.2 billion under Horizon Europe for healthcare digitization through 2027. - WHO estimates there is still a 60% gap in baseline imaging capability in low- and middle-income countries. - GE HealthCare holds an estimated 16% to 20% revenue share and leads with a broad modality portfolio and its Edison AI platform. - Siemens Healthineers holds an estimated 15% to 19% share and commercially launched the NAEOTOM Alpha photon-counting CT in 2021. - Philips Healthcare holds an estimated 10% to 14% share and is strong in image-guided therapy and point-of-care ultrasound. - X-ray was the largest modality in 2025, with a 31.25% share. - Computed tomography was the fastest-growing modality, with a 6.85% CAGR. - MRI generated USD 18.40 billion in 2025. - Ultrasound is growing at a 4.50% CAGR. - Diagnostic imaging was the largest application segment in 2025, with a 62.15% share. - Therapeutic and interventional imaging was the fastest-growing application, with a 7.10% CAGR. - Research and clinical trials accounted for USD 8.22 billion in 2025. - Hospitals were the dominant end user in 2025, with a 65.78% share. - Diagnostic imaging centers were the fastest-growing end user, with a 7.62% CAGR. - North America led the market in 2025 with 44.89% of global revenue, or about USD 37.55 billion. - Europe held about 27% of global revenue in 2025. - Asia-Pacific was the fastest-growing region, with a projected 5.93% CAGR. - South America was valued at USD 4.18 billion in 2025. - The Middle East and Africa reached USD 3.43 billion in 2025. - The top five players hold an estimated 60% to 68% of global revenue. - GE HealthCare completed its acquisition of Intelerad in March 2026. - GE HealthCare integrated its bkActiv intraoperative ultrasound system with Medtronic’s Stealth AXiS surgical navigation platform in May 2026. - Bracco Imaging signed a multi-year master research agreement with NYU Langone Health in May 2026.

Between the lines: - The forecast suggests imaging is becoming a software-and-services business as much as a hardware market. - Outpatient shifts and AI workflow tools favor vendors that can monetize installed bases through recurring software, cloud and service contracts. - Emerging-market hospital buildouts could widen demand, but access gaps remain a structural constraint. - The competitive picture still favors large OEMs with broad portfolios, but the report points to pressure from cloud-based imaging platforms and specialized AI tools.

What's next: - Market Research Future expects new opportunities in greenfield installations, compact cloud-connected devices and premium replacement cycles. - The report sees growth in photon-counting and spectral detector systems. - AI-as-a-Service, software-defined imaging and managed-service agreements are expected to become more important revenue streams. - Theranostics and image-guided interventions are likely to expand in oncology pathways. - By 2035, vendors that shift from selling equipment to running imaging platforms could raise recurring revenue above 40% through managed-service agreements.

The bottom line: - The medical imaging market is on track for steady, tech-led growth through 2035, with aging demographics, AI adoption and outpatient care reshaping where and how scans are delivered.